Glaucoma treatment market was valued at $7.2 billion in 2025 and is projected to reach $10.8 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The global glaucoma treatment market is witnessing strong momentum due to the increasing prevalence of glaucoma and the critical need for early intervention to prevent irreversible vision loss. As awareness of the disease grows, patients are seeking timely access to effective therapies, including prescription eye drops, oral medications, laser therapies, and surgical procedures. This demand is further reinforced by healthcare providers emphasizing proactive disease management and patients’ preference for minimally invasive options, boosting adoption across hospitals, retail pharmacies, and online channels. Recent FDA approvals and product launches have accelerated access to advanced therapies, enhancing treatment options for both open-angle and closed-angle glaucoma patients.
Browse the full report description of “Global Glaucoma Treatment Market Size, Share & Trends Analysis Report By Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, and Congenital Glaucoma), By Distribution Channel (Hospitals PHARMACY, RETAIL Pharmacy, and Online Pharmacy), By Drug Class (Prostaglandin Analogues, Alpha Agonist, Cholinergic, Beta Blockers, and Carbonic Anhydrase Inhibitors), Forecast Period 2026-2035.” Of https://www.omrglobal.com/industry-reports/glaucoma-treatment-market
Supporting this trend, glaucoma currently affects millions globally, with US patient numbers projected to rise from 5 million to 6.3 million by 2050. Traditional treatments such as prostaglandin analogues, beta blockers, alpha agonists, cholinergic agents, and carbonic anhydrase inhibitors remain central to therapy, helping reduce intraocular pressure and preserve vision. The increasing pipeline of FDA-approved drugs and new product launches is expanding therapeutic choices, improving patient adherence, and driving market growth across multiple distribution channels.
Market Coverage
Key questions addressed by the report.
Global Glaucoma Treatment Market Report Segment
By Drug Class
By Disease Indication
By Distribution Channel
Global Glaucoma Treatment Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/glaucoma-treatment-market